Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cadherins | 5 | 2024 | 174 | 1.530 |
Why?
|
| Skin Diseases | 2 | 2018 | 136 | 1.010 |
Why?
|
| STAT3 Transcription Factor | 3 | 2018 | 215 | 0.990 |
Why?
|
| Adenosine | 4 | 2019 | 127 | 0.920 |
Why?
|
| Scleroderma, Systemic | 3 | 2018 | 114 | 0.720 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 3 | 2019 | 129 | 0.660 |
Why?
|
| Transforming Growth Factor beta | 3 | 2019 | 446 | 0.630 |
Why?
|
| Extracellular Matrix | 2 | 2019 | 223 | 0.600 |
Why?
|
| Naphthols | 1 | 2018 | 8 | 0.590 |
Why?
|
| Skin | 2 | 2018 | 515 | 0.560 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 4423 | 0.540 |
Why?
|
| Sulfonamides | 1 | 2018 | 270 | 0.510 |
Why?
|
| Myofibroblasts | 2 | 2015 | 59 | 0.490 |
Why?
|
| Epithelial Cells | 2 | 2015 | 871 | 0.410 |
Why?
|
| Interleukin-6 | 2 | 2014 | 405 | 0.400 |
Why?
|
| Equilibrative Nucleoside Transport Proteins | 1 | 2012 | 1 | 0.390 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 871 | 0.370 |
Why?
|
| Lung Injury | 3 | 2019 | 119 | 0.370 |
Why?
|
| Pulmonary Fibrosis | 4 | 2022 | 108 | 0.370 |
Why?
|
| Capillary Permeability | 1 | 2012 | 73 | 0.370 |
Why?
|
| Endothelial Cells | 2 | 2013 | 505 | 0.370 |
Why?
|
| Liver | 1 | 2019 | 1752 | 0.360 |
Why?
|
| Macrophages | 4 | 2024 | 644 | 0.340 |
Why?
|
| Lung | 4 | 2015 | 1509 | 0.320 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1850 | 0.310 |
Why?
|
| Adenosine Deaminase | 6 | 2019 | 91 | 0.290 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 447 | 0.290 |
Why?
|
| Pneumonia | 1 | 2011 | 331 | 0.270 |
Why?
|
| Fibrosis | 3 | 2018 | 393 | 0.270 |
Why?
|
| Signal Transduction | 3 | 2018 | 4463 | 0.270 |
Why?
|
| Mice | 14 | 2024 | 17578 | 0.260 |
Why?
|
| Bleomycin | 3 | 2022 | 110 | 0.240 |
Why?
|
| Animals | 16 | 2024 | 33175 | 0.240 |
Why?
|
| Hyaluronic Acid | 2 | 2019 | 101 | 0.240 |
Why?
|
| Receptor, Adenosine A2B | 3 | 2019 | 9 | 0.230 |
Why?
|
| Dermatologic Agents | 1 | 2023 | 29 | 0.200 |
Why?
|
| Phagocytosis | 1 | 2024 | 191 | 0.190 |
Why?
|
| Psoriasis | 1 | 2023 | 50 | 0.190 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2022 | 15 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2902 | 0.180 |
Why?
|
| Apoptosis | 3 | 2013 | 1801 | 0.180 |
Why?
|
| Dendritic Cells | 1 | 2024 | 435 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 219 | 0.170 |
Why?
|
| Collagen | 2 | 2019 | 294 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 4503 | 0.160 |
Why?
|
| Mice, Knockout | 5 | 2024 | 3705 | 0.160 |
Why?
|
| Monocytes | 1 | 2022 | 329 | 0.160 |
Why?
|
| Carbon Tetrachloride | 1 | 2019 | 6 | 0.160 |
Why?
|
| Hepatic Stellate Cells | 1 | 2019 | 24 | 0.150 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 90 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2019 | 233 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2013 | 613 | 0.130 |
Why?
|
| Pentostatin | 2 | 2013 | 11 | 0.120 |
Why?
|
| Adenosine Deaminase Inhibitors | 2 | 2013 | 6 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2013 | 84 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 118 | 0.120 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 48 | 0.110 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2014 | 41 | 0.110 |
Why?
|
| Cattle | 2 | 2013 | 535 | 0.110 |
Why?
|
| Biopsy | 1 | 2017 | 1219 | 0.110 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2013 | 8 | 0.110 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2013 | 15 | 0.110 |
Why?
|
| Deoxycytidine Kinase | 1 | 2013 | 2 | 0.100 |
Why?
|
| Deoxyadenine Nucleotides | 1 | 2013 | 6 | 0.100 |
Why?
|
| Deoxyadenosines | 1 | 2013 | 9 | 0.100 |
Why?
|
| Interleukin-8 | 1 | 2013 | 203 | 0.100 |
Why?
|
| Stress Fibers | 1 | 2012 | 4 | 0.100 |
Why?
|
| Smoke | 1 | 2013 | 52 | 0.100 |
Why?
|
| Adherens Junctions | 1 | 2012 | 15 | 0.100 |
Why?
|
| Mitochondria, Muscle | 1 | 2012 | 36 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 44 | 0.090 |
Why?
|
| Electric Impedance | 1 | 2012 | 67 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 990 | 0.090 |
Why?
|
| Hypoxia | 1 | 2013 | 247 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 131 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2012 | 581 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 179 | 0.090 |
Why?
|
| Pulmonary Alveoli | 1 | 2011 | 135 | 0.080 |
Why?
|
| Female | 8 | 2024 | 67886 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2014 | 822 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 64 | 0.080 |
Why?
|
| Rats | 2 | 2013 | 3390 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 488 | 0.080 |
Why?
|
| Humans | 10 | 2024 | 125883 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 444 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 752 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 496 | 0.070 |
Why?
|
| Male | 7 | 2022 | 62056 | 0.060 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2024 | 11 | 0.050 |
Why?
|
| Phagocytes | 1 | 2024 | 22 | 0.050 |
Why?
|
| Terpenes | 1 | 2024 | 30 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2024 | 105 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2024 | 170 | 0.050 |
Why?
|
| Antigens, Ly | 1 | 2022 | 32 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 2565 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2019 | 1177 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2022 | 298 | 0.040 |
Why?
|
| Hyaluronan Synthases | 1 | 2019 | 12 | 0.040 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2019 | 12 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2023 | 1589 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2023 | 542 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 1429 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 95 | 0.030 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2013 | 4 | 0.030 |
Why?
|
| Purines | 1 | 2013 | 109 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 114 | 0.030 |
Why?
|
| 2-Chloroadenosine | 1 | 2013 | 5 | 0.030 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2013 | 6 | 0.020 |
Why?
|
| Mice, Inbred AKR | 1 | 2013 | 15 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2013 | 286 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 115 | 0.020 |
Why?
|
| Endothelium | 1 | 2013 | 62 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 396 | 0.020 |
Why?
|
| Ligands | 1 | 2013 | 478 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 722 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 240 | 0.020 |
Why?
|
| Neutrophils | 1 | 2013 | 351 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 1001 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2013 | 313 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 1193 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 844 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 829 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1673 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2550 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 223 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3600 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2551 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 1039 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 720 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2010 | 284 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12354 | 0.020 |
Why?
|
| Child | 1 | 2024 | 25059 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 20022 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 27322 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 30246 | 0.010 |
Why?
|